Übersetzung für "Lack of momentum" in Deutsch

There is still a lack of momentum in domestic demand, especially in private consumption.

There is a lack of momentum across the whole market, resulting in continuing intensified predatory competition.

Environmentalists fear there is now a lack of political momentum behind the green agenda.

In Germany, RST's core market, the lack of renovation momentum is having an effect.

The EU welcomes the fact that both parties continue to hold talks even if we note with regret the lack of results and the lack of momentum.

The EESC is greatly concerned at the current lack of momentum in European economic governance.

The draft opinion is greatly concerned at the current lack of momentum in European economic governance and therefore outlines the various viewpoints that have driven the political and economic debate over the six years, in order to provide an assessment of the reform process and to outline guidelines on strengthening European economic governance.

The European Economic and Social Committee is greatly concerned at the current lack of momentum in European economic governance.

In the context of the lack of macroeconomic growth momentum, this is a good performance which confirms Brenntag's strong positioning in Europe.

As expected, the situation on the European cartonboard and folding carton markets started to get more challenging due to a lack of momentum.

Against the background of weak economic performance and increasing uncertainty, the overall general conditions for our business show a lack of momentum.

You would be surprised by the lack of momentum created by the Blaues Fest, a family festivity organised by the local administrative structure of the Freedom Party of Austria (FPÖ).

If the pyramid turns easily and smoothly when manually pushed then the lack of momentum is often due to the position of the blades.

However, when it comes to the pricing of medicine today, there are still various false incentives and inadequate regulations (e.g. strict margin rules, arbitrary innovation supplement, unclear application of the foreign price comparison and therapeutic cross-comparison, lack of pricing momentum, no annual review of prices by the FOPH, no adequate licensing and pricing rules for new and innovative therapies such as CAR-T cell therapy, etc.): This inadequate regulation and false incentives mean that medication in Switzerland is still expensive compared with medication abroad, that unreasonable price demands by the industry go unchallenged and that fewer generic medicines are dispensed, among other things.